Sort
3,198 grants matching “mrna vaccine”
Non-viral gene therapy with eCD4-Ig
$917,294Brian D Quinlan · Emmune, Inc · R56 · FY2025 · AI
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination
$916,382John Ross Teijaro · Scripps Research Institute, The · R01 · FY2022 · AI
Combining membrane Env vaccine regimens to elicit multiple bnAb lineages and consistent cross-neutralization of HIV
$912,596Michael B Zwick · Scripps Research Institute, The · R01 · FY2025 · AI
Vector Biological Studies in Leishmaniasis
$911,807David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Advancing HIV Vaccine Development with a Lipid Nanodisc Platform
$910,905Kimmo Ilmari Rantalainen · Scripps Research Institute, The · R56 · FY2025 · AI
Development of a rapid response nucleic acid vaccine strategy for coronavirusepidemics
$908,934Kenneth C Bagley · Orlance, Inc. · R44 · FY2020 · AI
Poxvirus Gene Expression and DNA Replication
$908,727Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Core B: GMP Cell and RNA Manufacturing
$907,314Bruce L. Levine · University Of Pennsylvania · P01 · FY2018 · CA
Carbon Nanotube Enabled Delivery of mRNA for an HIV Vaccine Candidate
$903,639Yang Xu · Luna Labs Usa, Llc · R44 · FY2024 · MH
Developing Durable, Env-Boosted CAR T Cells for HIV Cure
$893,464Christopher W Peterson · Fred Hutchinson Cancer Center · R01 · FY2023 · AI
HIV mRNA vaccine strategies for efficient priming, diversity and durability of immune responses
$892,826Parham Ramezani-Rad · La Jolla Institute For Immunology · R61 · FY2024 · AI
An Env apex-focused HIV-1 vaccine strategy
$891,681Michael R. Farzan · Boston Children'S Hospital · R01 · FY2024 · AI
Therapeutic vaccination to boost autologous neutralizing antibodies for ART free HIV Control
$891,410Katharine June Bar · University Of Pennsylvania · R37 · FY2025 · AI
Function of granulysin
$888,707Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Identification of human tumor-associated antigens
$887,872Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
$886,934Koen K Van Rompay · Duke University · P01 · FY2020 · AI
CCR Genomics Core
$886,180Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination
$884,886John Ross Teijaro · Scripps Research Institute, The · R01 · FY2024 · AI
Host-pathogen interactions in filarial worm infections
$884,615Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Immunotherapeutic Approaches for AIDS
$884,441George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Novel Hepatitis B Vaccine and Immunotherapy
$883,119Mansun Law · Scripps Research Institute, The · R56 · FY2024 · AI
Efficacy of Strain 68-1 RhCMV Vectors Expressing 5' Leader Polypeptides
$882,566Scott G Hansen · Oregon Health & Science University · R01 · FY2016 · AI
Structural characterization of MPER-TM immunogens
$881,996Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2025 · AI
Designing HIV-1 envelope immunogens to maximize neutralization breadth through use of multiple founder envelope antigens
$880,838Sandhya Vasan · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2024 · AI
Optimizing glycan shield coverage, germline B cell receptor binding and epitope diversity of V2-apex targeted HIV-1 Env immunogens
$880,342Beatrice H Hahn · University Of Pennsylvania · R37 · FY2019 · AI